← Herbalife Nutrition overview

Herbalife Nutrition vs Henkel AG & Co. KGaA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Herbalife Nutrition Ltd (HLF)

Q3 2026
▲2▼1

Herbalife: Buyback, Steady Sales, but CEO Exit and Weak Guidance

  • New $250M buyback signals confidence The board approved a $250 million share buyback over three years, a direct return of cash to shareholders. This can support the stock price by reducing shares outstanding and showing management believes the shares are undervalued.

    This is a new capital-return event that directly affects HLF's share count and investor sentiment.

  • CEO departure spooks investors Herbalife's CEO left the company, causing the stock to drop 13% in one day. Leadership changes can create uncertainty about strategy and execution, which weighs on the share price.

    This is a new, significant event that explains a sharp negative price move and adds uncertainty.

  • Q2 revenue beat but EPS miss and weak guidance Second-quarter revenue rose 5.4% to $1.33 billion, beating estimates, but earnings per share missed by 19% and next-quarter EBITDA guidance disappointed. The mixed results create uncertainty about future profitability.

    This is the core earnings event that drives both positive and negative reactions, and it is new this period.

  • Reaffirmed guidance and steady sales growth Herbalife reaffirmed its 2026 guidance and expects a fifth straight quarter of year-over-year sales growth. This consistency can reassure investors that the business is stable despite recent headwinds.

    This is a new update that reinforces the growth narrative and counters some negative sentiment.

August 2026
▲2▼1

Herbalife: Buyback, Steady Sales, but CEO Exit and Weak Guidance

  • New $250M buyback signals confidence The board approved a $250 million share buyback over three years, a direct return of cash to shareholders. This can support the stock price by reducing shares outstanding and showing management believes the shares are undervalued.

    This is a new capital-return event that directly affects HLF's share count and investor sentiment.

  • CEO departure spooks investors Herbalife's CEO left the company, causing the stock to drop 13% in one day. Leadership changes can create uncertainty about strategy and execution, which weighs on the share price.

    This is a new, significant event that explains a sharp negative price move and adds uncertainty.

  • Q2 revenue beat but EPS miss and weak guidance Second-quarter revenue rose 5.4% to $1.33 billion, beating estimates, but earnings per share missed by 19% and next-quarter EBITDA guidance disappointed. The mixed results create uncertainty about future profitability.

    This is the core earnings event that drives both positive and negative reactions, and it is new this period.

  • Reaffirmed guidance and steady sales growth Herbalife reaffirmed its 2026 guidance and expects a fifth straight quarter of year-over-year sales growth. This consistency can reassure investors that the business is stable despite recent headwinds.

    This is a new update that reinforces the growth narrative and counters some negative sentiment.

Latest
▲2▼1

Herbalife: Buyback, Steady Sales, but CEO Exit and Weak Guidance

  • New $250M buyback signals confidence The board approved a $250 million share buyback over three years, a direct return of cash to shareholders. This can support the stock price by reducing shares outstanding and showing management believes the shares are undervalued.

    This is a new capital-return event that directly affects HLF's share count and investor sentiment.

  • CEO departure spooks investors Herbalife's CEO left the company, causing the stock to drop 13% in one day. Leadership changes can create uncertainty about strategy and execution, which weighs on the share price.

    This is a new, significant event that explains a sharp negative price move and adds uncertainty.

  • Q2 revenue beat but EPS miss and weak guidance Second-quarter revenue rose 5.4% to $1.33 billion, beating estimates, but earnings per share missed by 19% and next-quarter EBITDA guidance disappointed. The mixed results create uncertainty about future profitability.

    This is the core earnings event that drives both positive and negative reactions, and it is new this period.

  • Reaffirmed guidance and steady sales growth Herbalife reaffirmed its 2026 guidance and expects a fifth straight quarter of year-over-year sales growth. This consistency can reassure investors that the business is stable despite recent headwinds.

    This is a new update that reinforces the growth narrative and counters some negative sentiment.

Henkel AG & Co. KGaA (HEN.XETRA)